EZH2 and colorectal cancer: miRNA‐124 has been described as a tumor suppressor, preventing development of a malignant phenotype in the cancer cell by the downregulation of several pathways including STAT3 signaling in colorectal cancer or EZH2 in gastric and hepatocellular cancers 33, 34, 35.